ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,074 | +0.5% | 6,374 | -6.8% | 0.00% | – |
| Q2 2023 | $368,142 | +145.8% | 6,839 | +81.4% | 0.00% | – |
| Q1 2023 | $149,785 | -1.0% | 3,771 | +0.3% | 0.00% | – |
| Q4 2022 | $151,265 | +24.0% | 3,760 | -0.3% | 0.00% | – |
| Q3 2022 | $122,000 | +8.9% | 3,771 | +0.9% | 0.00% | – |
| Q2 2022 | $112,000 | +3.7% | 3,739 | -2.3% | 0.00% | – |
| Q1 2022 | $108,000 | -29.4% | 3,828 | +15.4% | 0.00% | – |
| Q4 2021 | $153,000 | +43.0% | 3,316 | +1.5% | 0.00% | – |
| Q3 2021 | $107,000 | -22.5% | 3,267 | -16.9% | 0.00% | – |
| Q2 2021 | $138,000 | -14.8% | 3,930 | -12.2% | 0.00% | – |
| Q1 2021 | $162,000 | +36.1% | 4,478 | +8.5% | 0.00% | – |
| Q4 2020 | $119,000 | +3.5% | 4,127 | +0.9% | 0.00% | – |
| Q3 2020 | $115,000 | +0.9% | 4,090 | +16.2% | 0.00% | – |
| Q2 2020 | $114,000 | -13.0% | 3,521 | +9.7% | 0.00% | – |
| Q1 2020 | $131,000 | -46.7% | 3,209 | -19.8% | 0.00% | – |
| Q4 2019 | $246,000 | -14.9% | 4,001 | +0.6% | 0.00% | – |
| Q3 2019 | $289,000 | -14.7% | 3,977 | -3.8% | 0.00% | – |
| Q2 2019 | $339,000 | +313.4% | 4,132 | +255.0% | 0.00% | – |
| Q1 2019 | $82,000 | +67.3% | 1,164 | +5.4% | 0.00% | – |
| Q4 2018 | $49,000 | -14.0% | 1,104 | +8.2% | 0.00% | – |
| Q3 2018 | $57,000 | -13.6% | 1,020 | +4.0% | 0.00% | – |
| Q2 2018 | $66,000 | +17.9% | 981 | +1.7% | 0.00% | – |
| Q1 2018 | $56,000 | -20.0% | 965 | -10.9% | 0.00% | – |
| Q4 2017 | $70,000 | +34.6% | 1,083 | +11.1% | 0.00% | – |
| Q3 2017 | $52,000 | -98.4% | 975 | -98.6% | 0.00% | -100.0% |
| Q2 2017 | $3,331,000 | -5.6% | 71,160 | -0.2% | 0.00% | 0.0% |
| Q1 2017 | $3,528,000 | -21.6% | 71,268 | -4.1% | 0.00% | -20.0% |
| Q4 2016 | $4,502,000 | -1.2% | 74,278 | +8.1% | 0.01% | 0.0% |
| Q3 2016 | $4,558,000 | +32.9% | 68,682 | +11.9% | 0.01% | +25.0% |
| Q2 2016 | $3,429,000 | +90.5% | 61,405 | +14.9% | 0.00% | +100.0% |
| Q1 2016 | $1,800,000 | +89900.0% | 53,456 | +121390.9% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 44 | +2.3% | 0.00% | – |
| Q2 2015 | $3,000 | +50.0% | 43 | +30.3% | 0.00% | – |
| Q1 2015 | $2,000 | -33.3% | 33 | -32.7% | 0.00% | – |
| Q4 2014 | $3,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |